loader2
Login Open ICICI 3-in-1 Account

Nifty500 Multicap Infrastructure 50:30:20 Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Narayana Hrudayalaya Ltd. 17 Nov 2025 12:19 PM

Q2FY26 Quarterly Result Announced for Narayana Hrudayalaya Ltd.

Healthcare Facilities company Narayana Hrudayalaya announced Q2FY26 results

  • Consolidated total operating revenue was Rs 16,438 million for Q2FY26 as compared to Rs 13,667 million in the corresponding period of the previous year, reflecting a change of 20.3 % YoY and 9.1% QoQ.
  • Consolidated EBITDA stood at Rs 4,265 million, reflecting a margin of 25.9% as against Rs 3,323 million in Q2FY25, translating into a change of 28.3% YoY and 18.2% QoQ.
  • Consolidated PAT stood at Rs 2,583 million, reflecting a margin of 15.7% as compared to Rs 1,993 million in Q2FY25, translating into a change of 29.6% YoY and 31.7% QoQ.
  • India operating revenue was Rs 12,347 million for Q2FY26 as compared to Rs 11,351 million in the corresponding period of the previous year, reflecting a change of 8.8% YoY and 9.0% QoQ.
  • Cayman operating revenue was Rs 4,316 million for Q2FY26 as compared to Rs 2,423 million in the corresponding period of the previous year, reflecting a change of 78.1% YoY and 8.8% QoQ.

Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said: “The second quarter of the fiscal year has delivered a strong performance after a steady start to the year. We are pleased to report the highest-ever revenue and profitability at both India and the Group level. The performance improvement in India is attributable to strong growth in domestic footfall and improvements in payor mix, along with positive traction from our Clinics outreach, resulting in the highest ever profitability margins. Our hospital business in Cayman continues to deliver robust performance, with the Insurance business showing strong growth, resulting in record revenues for the region. We are confident that the synergies between the hospital and insurance businesses will deliver steady growth going forward in the Cayman region. The domestic Integrated Care business continues to be on a strong growth path, with our clinics garnering sizeable footfalls across all locations, providing a positive thrust to the overall business. After a steady start, our domestic Insurance business has shown strong momentum this quarter and we expect to build on this further going forward. We will continue to invest in this business and are optimistic that it will be a significant driver of growth to the NH ecosystem. We thank the investor community for their faith in us and remain confident of delivering on expectations for the year.”

Result PDF

Healthcare Facilities company Max Healthcare Institute announced Q2FY26 results

  • Gross Revenue stood at Rs 2,692 crore, a growth of 21% YoY and 5% QoQ.
  • Network Operating EBITDA stood at Rs 694 crore, a growth of 23% YoY.
  • Operating Margin was 26.9% compared to 26.6% in Q2FY25 and 24.9% in Q1FY26.
  • Network PAT was Rs 554 crore, compared to Rs 349 crore in Q2FY25 and Rs 345 crore in Q1FY26, reflecting a growth of 59% YoY. This includes favourable tax impact of ~Rs 149 crore, arising from accounting of merger of two WoS i.e croreosslay Remedies Limited (CRL) and Jaypee Healthcare Limited (JHL). Excluding this one-time impact, PAT stood at Rs 406 crore, 16% YoY.
  • Free Cash from Operations was Rs 291 crore in Q2FY26 compared with Rs 464 crore in Q2FY25 and Rs 389 crore in Q1FY26.
  • EBITDA per bed was Rs 73.4 lakh compared to Rs 71.2 lakh in Q2FY25 and Rs 68.5 lakh in Q1FY26.
  • Bed occupancy for the quarter was at 77%, with Occupied Bed Days (OBDs) up by 19% YoY.
  • ARPOB for Q2FY26 stood at Rs 77.3k compared to Rs 76.2k in Q2FY25 and Rs 78.0k in Q1FY26.
  • Free treatment provided to 42,522 patients in OPD and 1,547 patients in IPD from the economically weaker sections by the Network Hospitals.
  • Pursuant to the binding term sheet executed in July 2025, JHL, a wholly owned subsidiary (WoS) of the Company, has divested its hospitals located in Village Chitta and Anoopshahr, District Bulandshahr effective September 18, 2025.
  • Hon’ble NCLT Chandigarh Bench approved Scheme of Amalgamation of JHL and CRL, both wholly owned subsidiaries of the Company, with an appointed date of October 5, 2024.
  • The 160 bed brownfield tower, including the additional radiation oncology program, has been commissioned at MSSH Mohali.
  • The 268 bed brownfield tower at Nanavati-Max, Mumbai, is to be commissioned next week.

Abhay Soi, Chairman & Managing Director, Max Healthcare Institute, said: “We continued our strong performance this quarter with Revenue and Operating EBITDA growth of 21% and 23%, respectively. Integration of newly acquired Max Super Speciality Hospital, Noida (erstwhile Jaypee Hospital) is nearly complete. Commissioning of brownfield capacities at Max Mohali, Nanavati-Max and Max Smart is underway and operating leverage from the same will start reflecting in the financial and operating metrics soon.

On-streaming of brownfield capacities and strong underlying demand in our micro markets will further bolster our leadership position in the delivery of quality healthcare to our patients”.

Result PDF

Exploration & Production company Oil India announced Q2FY26 results

  • The Company sustained its consolidated turnover at Rs 9,175 crore in Q2FY26 vis-a-vis Rs 8,136 crore in Q2FY25.
  • OIL achieved a standalone PAT of Rs 1,044 crore in Q2FY26 vis-à-vis Rs 1,834 crore achieved in Q2FY25.
  • The Board of Directors of the Company has recommended an Interim Dividend of Rs 3.50/- per fully paid equity share.

Result PDF

Auto Parts & Equipment company Exide Industries announced Q2FY26 results

  • Revenue: Rs 4,178 crore against Rs 4,267 crore during Q2FY25.
  • EBITDA: Rs 395 crore against Rs 484 crore during Q2FY25.
  • PBT: Rs 298 crore against Rs 399 crore during Q2FY25.
  • PAT: Rs 221 crore against Rs 298 crore during Q2FY25.
  • EPS: Rs 2.60 for Q2FY26.

Avik Roy, MD & CEO, said: 'We had a strong first half of the quarter until mid-August when the GST cut was announced. The growth was muted in the second half, especially in trade business, driven by channel destocking. However, it is a welcome move by the government as it will drive demand in H2FY26. Global trade situation remained uncertain and impacted our exports.

Domestic Macro outlook is favourable with low inflation, low interest rates and higher disposable incomes. We expect the strong growth momentum, especially in Trade and Automotive OEM business, to be back in Q3.

There is continuous pressure from input material costs. In this environment, the company's priority has been on managing profitable growth and focusing on preserving cash. We proactively cut down production in the second half of the quarter in anticipation of the muted demand from channel partners. This helped us to reduce our inventory levels. Investments in our manufacturing technologies have started showing results which will be further realized as volumes grow.

In our lithium-ion cell manufacturing project, construction work is going on in full swing to ensure timely project completion. We wish to commercialise operations in FY26.'

Result PDF

Construction & Engineering company GMR Airports announced Q2FY26 results

  • Total Income: Rs 3,754 crore against Rs 2,598 crore during Q2FY25.
  • EBITDA: Rs 1,531 crore against Rs 962 crore during Q2FY25.
  • PBT: Rs 103 crore against Rs -386 crore during Q2FY25.
  • PAT: Rs 35 crore against Rs -429 crore during Q2FY25.

Result PDF

Compressors & Pumps company Elgi Equipments announced Q2FY26 results

Consolidated Financial Highlights:

  • Consolidated sales for Q2FY26 of Rs 968 crore compared to Rs 869 crore in Q2FY25, representing a growth of 11 %.
  • Consolidated PAT of Rs 121 crore for the quarter, compared to Rs 95 crore in Q2FY25, representing a growth of 27%.

Standalone Financial Highlights:

  • Standalone sale for Q2FY26 was Rs 568 crore compared to Rs 531 crore for Q2FY25, representing a growth of 7%.
  • Standalone PAT for the quarter was Rs 91 crore as compared to Rs 98 crore in Q2FY25.

Result PDF

Realty company Prestige Estates Projects announced Q2FY26 results

  • Company reported Revenue of Rs 26,978 million, marking an increase of 11.3% YoY.
  • EBITDA stood at Rs 11,759 million, up 56.64% YoY.
  • EBITDA margin of 43.59%.
  • Profit After Tax (PAT) grew by 95.14% YoY to Rs 4,578 million.
  • PAT margin of 16.97%.

Irfan Razack, Chairman and Managing Director, Prestige Group, said: “We are pleased to share yet another period of steady financial and operational performance. The H1FY26 has been particularly encouraging, with robust sales momentum and strong cash flows underscoring the enduring trust that homebuyers and investors place in the Prestige brand. Our focus remains on timely delivery, prudent capital allocation, and expanding our footprint across key growth markets. With a healthy launch pipeline ahead, we are well-positioned to sustain our growth trajectory through the remainder of the year.”

Result PDF

Healthcare Facilities company Fortis Healthcare announced Q2FY26 results

  • Consolidated Revenues at Rs 2,331 crore, up 17.3% YoY.
  • Operating EBITDA Margin at 23.9% vs 21.9% in Q2FY25.
  • Profit after Tax at Rs 329 crore, up 70.3% YoY.
  • Hospital Business Revenues at Rs 1,974 crore, up 19.3% YoY.
  • Operating EBITDA margin at 22.9% vs 21.4% in Q2FY25.

Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare said: “We have maintained a healthy growth momentum across both our hospital and diagnostics businesses. In the hospital segment, key specialties such as Oncology and Renal Sciences grew by 29% and 22%, respectively, compared to the same period last year. Our growth and expansion strategy is accelerating on multiple fronts. The company recently entered into a lease agreement for a ~200-bedded multi-specialty hospital in Greater Noida, a facility that we had previously been managing under an O&M arrangement. This expands our presence in Delhi NCR to ~2,100 beds. The integration of Gleneagles units under the O&M arrangement with Fortis is progressing well and we have also made our foray in Lucknow with an O&M arrangement for a 550 bedded super specialty hospital to be constructed by the Ekana Group.”

“In the diagnostics business, we continue to witness a buoyant recovery in both revenue and EBITDA margin and expect this positive momentum to continue going forward.”

Result PDF

Industrial Machinery company Kirloskar Oil Engines announced Q2FY26 results

Consolidated Financial Highlights:

  • Revenue from continuing operations at Rs 1,948 crore for Q2FY26 vs Rs 1,499 crore for Q2FY25; 30% increase YoY.
  • Net profit from continuing operations# at Rs 159 crore for Q2FY26 vs Rs 106 crore for Q2FY25; 51% increase YoY.

Standalone Financial Highlights:

  • Net sales at Rs 1,593 crore for Q2FY26 vs Rs 1,184 crore for Q2FY25; 35% increase YoY.
  • EBITDA at Rs 214 crore for Q2FY26 vs Rs 148 crore for Q2FY25; 45% increase YoY.
  • EBITDA margin at 13.4% for Q2FY26 vs 12.4% for Q2FY25.
  • Net profi# at Rs 141 crore for Q2FY26 vs Rs 98 crore for Q2FY25; 44% increase YoY.
  • Cash and cash equivalents of, 475 crore

Gauri Kirloskar, Managing Director, Kirloskar Oil Engines, said: " Kirloskar Oil Engines Limited (KOEL) has delivered its best-ever performance in Q2FY26, marking a key milestone in the company's growth journey. We crossed the, 1,500 crore revenue mark for the first time in a quarter and achieved our highest-ever Hl sales of, 3,027 crore. All segments within the standalone business recorded double-digit growth, reflecting our strong market position and operational excellence. The Power Generation Business Unit continued its robust performance, supported by our extensive distribution network, strong brand equity, and ongoing innovation in engine and generator technology. On October 10th, we also announced a strategic restructuring of our B2C operations, transferring this business to our wholly owned subsidiary, La-Gajjar Machineries Private Limited, through a slump sale. This step strengthens our focus and aligns with our long-term strategic vision to reach a USD 2 billion top line by 2030. We are encouraged by the progress made and remain focused on executing our strategic priorities with discipline and consistency."

Result PDF

Electric Utilities company Tata Power Company announced Q2FY26 results

  • Revenue momentum continues: Q2FY26 Revenue up 3% to Rs 15,769 crore; H1FY26 up 4% to Rs 33,233 crore, driven by strong performance across core businesses EBITDA surges: Q2FY26 EBITDA increases 6% to Rs 4,032 crore; H1FY26 rises 11 % to Rs 7,961 crore, reflecting operating efficiency and well diversified portfolio.
  • Renewables business outperforms: Segment PAT up 70 % to Rs 511 crore in Q2FY26; EBITDA up 57% to Rs 1,575 crore, Revenue up 89% to Rs 3,613 crore reflecting strength of strategic investment in Solar Manufacturing and Rooftop business delivering stellar gains.
  • Solar Cell and Module manufacturing achieved output of 928 MW of Cells & 970 MW of Modules in Q2FY26. 809 MW of DCR modules dispatched in Q2, highest ever single quarter dispatch.
  • Global acknowledgement: TP Solar earns Bloomberg NEF Tier-1 manufacturer status, enhancing export prospects from its 4.3 GW Tirunelveli facility. Additionally, the plant is also included in ALMM List II.
  • Rooftop solar scales new highs: Order book stands at Rs 1,116 crore. Pan-India network of 644 channel partners and over 2000 retailers.
  • Transmission business overall PAT grew to Rs 120 crore (up 41 % YoY) in Q2FY26.
  • Distribution business overall PAT grew to Rs 557 crore (up 34 % YoY) in Q2FY26. The Company is actively exploring the upcoming opportunities in Power Distribution in Maharashtra, Goa and Uttar Pradesh
  • Strengthening regional energy security: Construction commenced for the 600 MW Khorlochhu Hydro Project in Bhutan in which Tata Power has 40% stake, part of a 5 GW clean energy partnership. The plant has signed loan agreement worth Rs 4,829 crore with PFC.
  • Firming up RTC renewable supply: Work commenced on 1,000 MW Bhivpuri PSP in Maharashtra to enable firm, dispatchable green power supply.

Praveer Sinha, CEO & Managing Director, Tata Power, said: “Tata Power has reported a robust performance in Q2FY26 and H1FY26, reflecting the strength of strategic initiatives and decisions taken by Company towards its integrated and diversified business model. Growth continues across conventional generation, clean energy, and consumer-focused distribution.

Tata Power is very well positioned to expand further with 10 GW of clean capacity under construction including a healthy pipeline of 5 GW Hybrid and FDRE projects. The Company’s backward-integrated solar manufacturing facilities are operating at full capacity, with ALMMlisted modules and cells supporting the “Make in India” clean energy push.

The rooftop solar segment continues to lead the industry with record installations, while our Discoms drive service excellence across a growing customer base of over 13 million. With proposed amendments to the Electricity Act, Tata Power is well positioned to expand its distribution footprint to 40 million consumers by 2030. As India’s power sector evolves, Tata Power remains committed to innovation, sustainability, and energy self-reliance across the value chain”.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app